Agenda

February 21, 2009

7:30 AM	Registration and Breakfast
8:25 AM	Introduction and Opening Remarks	Anthony Tolcher, MD
8:30 AM	What Are the New Agents and How Do They Work?	John G. Kuhn, Pharm.D
8:45 AM	What Are the New Agents on the Horizon?	Anthony Tolcher, MD
9:00 AM	Questions/Discussion
9:05 AM	New Agents in Colorectal Cancer for the Practicing Oncologist	David Ilson, MD
9:35 AM	Questions/Discussion
9:40 AM	Novel Agents in Lung Cancer for the Practicing Oncologist	Chandra P. Belani, MD
10:10 AM	Questions/Discussion
10:15 AM	BREAK
10:25 AM	New Agents in Kidney Cancer for the Practicing Oncologist	Daniel Petrylak, MD
10:55 AM	Questions/Discussion
11:00 AM	New Agents in Breast Cancer for the Practicing Oncologist: Consensus and Controversies	Mark Pegram, MD
11:30 AM	Questions/Discussion
11:35 AM	New Treatment Options for Sarcoma and GIST	Robert Benjamin, MD
12:05 PM	Questions/Discussion
12:10 PM	LUNCH
1:10 PM	New Agents in Hematological Malignancies	Michael Keating, MD
1:40 PM	Questions/Discussion
1:45 PM	Novel Agents in the Treatment of Ovarian and Gynecologic Cancers for the Practicing Oncologist	Tate Thigpen, MD
2:15 PM	Questions/Discussion
2:20 PM	Individualized Therapies--Pharmacogenomics	Howard McLeod, Pharm.D
2:50 PM	Questions/Discussion
2:55 PM	Brain Tumors: Incorporation of Novel Agent and Combinations	David Reardon, MD
3:25 PM	Questions/Discussion
3:30 PM	New Approaches in Supportive Care for the Practicing Physician	Jeffrey Crawford, MD
4:00 PM	Questions/Discussion
4:05 PM	Closing Remarks and Adjourn	Anthony Tolcher, MD